tirzepatide is ozempic Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Type 2 diabetes: Mounjaro superior

It's patient compliance, which correlates more strongly with affordability than formulation type

Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice

Sona, M

30 ( 120 .) : 2 () GLP-1 Oral semaglutide (OASIS trial) Orforglipron GLP-1 - GLP-1 Incretin - (GLP-1 RAs) 1521% GLP-1 (Wegovy) Wilding, J.P.H., et al

Therapeutic Research Protocol Dose: 1.0 2.0 mg (= 2040 clicks) Duration: 3 6 weeks Frequency: Daily until target pigmentation observed Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-dose schedule used in photoprotection and MC1R activation studies